These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8678427)

  • 21. Long-term effects of botulinum toxin injections in spasmodic dysphonia.
    Davidson BJ; Ludlow CL
    Ann Otol Rhinol Laryngol; 1996 Jan; 105(1):33-42. PubMed ID: 8546422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Spectral analysis of electromyograms in the strabismus cases--before and after botulinum toxin injection].
    Matsubayashi K; Kimura H; Tabuchi A
    Nippon Ganka Gakkai Zasshi; 1994 Apr; 98(4):404-7. PubMed ID: 8165976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A method for the treatment of abductor spasmodic dysphonia with botulinum toxin injections: a preliminary report.
    Rontal M; Rontal E; Rolnick M; Merson R; Silverman B; Truong DD
    Laryngoscope; 1991 Aug; 101(8):911-4. PubMed ID: 1865744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox).
    Brin MF; Blitzer A; Fahn S; Gould W; Lovelace RE
    Mov Disord; 1989; 4(4):287-96. PubMed ID: 2811888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of the interarytenoid muscle with botulinum toxin for laryngeal dystonia.
    Hillel AD; Maronian NC; Waugh PF; Robinson L; Klotz DA
    Ann Otol Rhinol Laryngol; 2004 May; 113(5):341-8. PubMed ID: 15174759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abductor laryngeal dystonia: a series treated with botulinum toxin.
    Blitzer A; Brin MF; Stewart C; Aviv JE; Fahn S
    Laryngoscope; 1992 Feb; 102(2):163-7. PubMed ID: 1738288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of botulinum toxin for pediatric cricopharyngeal achalasia.
    Messner A; Ho AS; Malhotra PS; Koltai PJ; Barnes MA
    Int J Pediatr Otorhinolaryngol; 2011 Jun; 75(6):830-4. PubMed ID: 21501882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia.
    Ford CN; Bless DM; Lowery JD
    Otolaryngol Head Neck Surg; 1990 Nov; 103(5 ( Pt 1)):752-8. PubMed ID: 2126097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the efficacy of unilateral versus bilateral botulinum toxin injections in the treatment of adductor spasmodic dysphonia.
    Maloney AP; Morrison MD
    J Otolaryngol; 1994 Jun; 23(3):160-4. PubMed ID: 8064952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laryngeal botulinum toxin injections for disabling stuttering in adults.
    Brin MF; Stewart C; Blitzer A; Diamond B
    Neurology; 1994 Dec; 44(12):2262-6. PubMed ID: 7991110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
    Troung DD; Rontal M; Rolnick M; Aronson AE; Mistura K
    Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laryngeal closure at the level of the false cord for the treatment of aspiration.
    Kitahara S; Ikeda M; Ohmae Y; Nakanoboh M; Inouye T; Healy GB
    J Laryngol Otol; 1993 Sep; 107(9):826-8. PubMed ID: 8228600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical application of botulinum toxin].
    Grandas F
    Neurologia; 1995; 10(6):224-33. PubMed ID: 7546812
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experiences with botulinum toxin injections against spasticity in children].
    Ramstad K; Karstensen AB; Risberg K; Bergsaker DK; Sommer FF
    Tidsskr Nor Laegeforen; 2006 Feb; 126(4):450-2. PubMed ID: 16477283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin a treatment of cricopharyngeal dysphagia after subarachnoid hemorrhage.
    Krause E; Schirra J; Gürkov R
    Dysphagia; 2008 Dec; 23(4):406-10. PubMed ID: 18437465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of neuromuscular activity on the response to botulinum toxin injections in spasmodic dysphonia.
    Wong DL; Adams SG; Irish JC; Durkin LC; Hunt EJ; Charlton MP
    J Otolaryngol; 1995 Aug; 24(4):209-16. PubMed ID: 8551532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cricopharyngeal achalasia in children: botulinum toxin injection as a tool for diagnosis and treatment.
    Scholes MA; McEvoy T; Mousa H; Wiet GJ
    Laryngoscope; 2014 Jun; 124(6):1475-80. PubMed ID: 24122834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcome of laryngotracheal separation for intractable aspiration pneumonia.
    Yamana T; Kitano H; Hanamitsu M; Kitajima K
    ORL J Otorhinolaryngol Relat Spec; 2001; 63(5):321-4. PubMed ID: 11528278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of vocal fold granuloma using botulinum toxin type A.
    Nasri S; Sercarz JA; McAlpin T; Berke GS
    Laryngoscope; 1995 Jun; 105(6):585-8. PubMed ID: 7769940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.